These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11085932)

  • 21. H2O2 induced hyperpolarization of pancreatic B-cells.
    Krippeit-Drews P; Lang F; Häussinger D; Drews G
    Pflugers Arch; 1994 Apr; 426(6):552-4. PubMed ID: 8052526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloxan inhibits glucose oxidation in the pancreatic islets.
    Ishibashi F; Sato T; Onari K; Kawate R
    Endocrinol Jpn; 1979 Jun; 26(3):395-7. PubMed ID: 383474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative importance of cellular uptake and reactive oxygen species for the toxicity of alloxan and dialuric acid to insulin-producing cells.
    Elsner M; Gurgul-Convey E; Lenzen S
    Free Radic Biol Med; 2006 Sep; 41(5):825-34. PubMed ID: 16895803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional restoration of cultured mouse pancreatic islets after in vitro exposure to alloxan.
    Eizirik DL; Sandler S
    Pharmacol Toxicol; 1988 Nov; 63(5):396-9. PubMed ID: 3070521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inositol trisphosphate-dependent periodic activation of a Ca(2+)-activated K+ conductance in glucose-stimulated pancreatic beta-cells.
    Ammälä C; Larsson O; Berggren PO; Bokvist K; Juntti-Berggren L; Kindmark H; Rorsman P
    Nature; 1991 Oct; 353(6347):849-52. PubMed ID: 1719424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of mitochondrial function affects cellular Ca2+ handling in pancreatic B-cells.
    Düfer M; Krippeit-Drews P; Drews G
    Pflugers Arch; 2002 May; 444(1-2):236-43. PubMed ID: 11976937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual effect of NO on K(+)(ATP) current of mouse pancreatic B-cells: stimulation by deenergizing mitochondria and inhibition by direct interaction with the channel.
    Drews G; Krämer C; Krippeit-Drews P
    Biochim Biophys Acta; 2000 Mar; 1464(1):62-8. PubMed ID: 10704920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of alloxan on the permeability of isolated pancreatic islets to horseradish peroxidase.
    Tomita T; Watanabe I
    Virchows Arch B Cell Pathol; 1976 Nov; 22(3):217-32. PubMed ID: 827103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential modulation of pancreatic beta-cell bursting by intracellular pH in the presence and absence of a K-ATP channel blocker.
    Barbosa RM; Salgado AP; Santos RM; Rosário LM
    FEBS Lett; 1993 Oct; 332(1-2):9-13. PubMed ID: 8405455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alloxan reversibly impairs glucagon release and glucose oxidation by pancreatic A2-cells.
    Ostenson CG
    Biochem J; 1980 Apr; 188(1):201-6. PubMed ID: 6996677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro.
    Jörns A; Munday R; Tiedge M; Lenzen S
    J Endocrinol; 1997 Nov; 155(2):283-93. PubMed ID: 9415063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of inhibition of calcium- and calmodulin-dependent protein kinase by alloxan.
    Norling LL; Colca JR; Brooks CL; Kloepper RF; McDaniel ML; Landt M
    Biochim Biophys Acta; 1984 Sep; 801(2):197-205. PubMed ID: 6236851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrical characteristics of pancreatic islet cells.
    Matthews EK; Sakamoto Y
    J Physiol; 1975 Mar; 246(2):421-37. PubMed ID: 1095720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis and mitochondrial damage in INS-1 cells treated with alloxan.
    Sakurai K; Katoh M; Someno K; Fujimoto Y
    Biol Pharm Bull; 2001 Aug; 24(8):876-82. PubMed ID: 11510477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro.
    Sandler S; Swenne I
    Diabetologia; 1983 Nov; 25(5):444-7. PubMed ID: 6228481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human islets in mixed islet grafts protect mouse pancreatic beta-cells from alloxan toxicity.
    Tyrberg B; Eizirik DL; Marklund SL; Olejnicka B; Madsen OD; Andersson A
    Pharmacol Toxicol; 1999 Dec; 85(6):269-75. PubMed ID: 10628902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel approach to in situ characterization of pancreatic beta-cells.
    Speier S; Rupnik M
    Pflugers Arch; 2003 Aug; 446(5):553-8. PubMed ID: 12774232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypan Blue as a marker of plasma membrane permeability in alloxan-treated mouse islet cells.
    Grankvist K; Lernmark A; Täljedal IB
    J Endocrinol Invest; 1979; 2(2):139-45. PubMed ID: 226577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p-Hydroxymercuribenzoate-induced hyperglycemia: influence of pre- and post-treatment with L-leucine, tolbutamide, D-mannoheptulose, insulin and alloxan.
    Boquist L
    J Endocrinol Invest; 1979; 2(4):413-7. PubMed ID: 395187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The bioelectrical properties of pancreatic islet cells: effects of diabetogenic agents.
    Dean PM; Matthews EK
    Diabetologia; 1972 Jul; 8(3):173-8. PubMed ID: 4261686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.